ALEMBIC PHARMACEUTICALS
Back to Balance Sheet
|
ALEMBIC PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹2,687 Cr | ₹2,514 Cr | ₹1,520 Cr | ₹1,641 Cr | ₹1,831 Cr |
What is the latest Total Current Liabilities ratio of ALEMBIC PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹2,687 Cr |
| Mar2025 | ₹2,514 Cr |
| Mar2024 | ₹1,520 Cr |
| Mar2023 | ₹1,641 Cr |
| Mar2022 | ₹1,831 Cr |
How is Total Current Liabilities of ALEMBIC PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,687 Cr | 6.86 | |
| Mar2025 | ₹2,514 Cr | 65.38 | |
| Mar2024 | ₹1,520 Cr | -7.35 | |
| Mar2023 | ₹1,641 Cr | -10.37 | |
| Mar2022 | ₹1,831 Cr | - | |
Compare Total Current Liabilities of peers of ALEMBIC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALEMBIC PHARMACEUTICALS | ₹16,626.5 Cr | 4.1% | 3.5% | -12.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,398.0 Cr | -0.4% | -3.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,664.0 Cr | 0.4% | 9.9% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,738.0 Cr | -3.4% | -4.2% | 37.1% | Stock Analytics | |
| CIPLA | ₹110,794.0 Cr | 0.5% | -3.2% | -12.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,749.4 Cr | 0.9% | 0% | -11% | Stock Analytics | |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC PHARMACEUTICALS | 4.1% |
3.5% |
-12.6% |
| SENSEX | -0.8% |
-3.8% |
-8.9% |
You may also like the below Video Courses